Basic and Diluted Loss per Share (Details) - $ / shares |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
|
Basic and Diluted Loss per Share (Details) [Line Items] | |||
Options to purchase shares | 873,172 | 890,493 | |
Exercise price (in Dollars per share) | $ 0.1516 | $ 0.1518 | |
Convertible shares of common stock | 7,731,043 | 7,731,043 | |
Preferred Stock [Member] | |||
Basic and Diluted Loss per Share (Details) [Line Items] | |||
Convertible shares outstanding | 256,242 | 120,899 | |
Common Stock [Member] | |||
Basic and Diluted Loss per Share (Details) [Line Items] | |||
Convertible shares outstanding | 77,366 | 12,042 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of shares of common stock issued as dividends during the period. Excludes stock splits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|